Research in virology (Res Virol)

Journal PubWeight™ 334.54‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity. 1992 2.74
2 Continuous cell lines and immune ascitic fluid pools in arbovirus detection. 1993 2.64
3 General aspects of the 1987 Rift Valley fever epidemic in Mauritania. 1989 1.91
4 Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction. 1994 1.86
5 Rift Valley fever epizootic in the central highlands of Madagascar. 1993 1.59
6 Genetic and serologic relatedness between Mycoplasma fermentans strains and a mycoplasma recently identified in tissues of AIDS and non-AIDS patients. 1990 1.54
7 Polio vaccines and the origin of AIDS. 1993 1.40
8 Mycoplasmas and leukaemia. 1992 1.39
9 Rift Valley fever on the east coast of Madagascar. 1992 1.35
10 Type- and group-specific polymerase chain reaction for adenovirus detection. 1994 1.35
11 Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera. 1989 1.34
12 The impact of dengue haemorrhagic fever on liver function. 1997 1.32
13 Sexual and transovarian transmission of Crimean-Congo haemorrhagic fever virus in Hyalomma truncatum ticks. 1992 1.31
14 KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. 1997 1.27
15 A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. 1996 1.24
16 Rift Valley fever among domestic animals in the recent West African outbreak. 1989 1.24
17 Hepatitis A and B infections in Yaoundé, Cameroon. 1989 1.23
18 Development of techniques to analyse the formation of HIV provirus in primary human macrophages. 1991 1.19
19 Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. 1989 1.18
20 Expression vectors for quantitating in vivo translational ambiguity: their potential use to analyse frameshifting at the HIV gag-pol junction. 1991 1.16
21 Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. 1997 1.15
22 Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. 1989 1.14
23 Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. 1990 1.13
24 Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign. 1990 1.13
25 Restriction site mapping of adenovirus type 8 genome types. 1991 1.12
26 PCR-based detection and typing of human adenoviruses in clinical samples. 1997 1.11
27 Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil. 1993 1.10
28 A dual dominant selection, dual marker gene amplification model for environmental surveillance of recombinant viral vaccines. 1991 1.09
29 Coronary artery lesions and human immunodeficiency virus infection. 1993 1.08
30 Nested RT-PCR for detection of sandfly fever virus, serotype Toscana, in clinical specimens, with confirmation by nucleotide sequence analysis. 1996 1.08
31 Dengue-2 virus isolation from humans during an epizootic in southeastern Senegal in November, 1990. 1992 1.07
32 Rift Valley fever antibody prevalence in domestic ungulates in Cameroon and several west African countries (1989-1992) following the 1987 Mauritanian outbreak. 1995 1.07
33 Electrostatic interactions in the early events of VSV infection. 1991 1.07
34 Electropherotypes, subgroups and serotypes of human rotavirus strains causing gastroenteritis in infants and young children in Palermo, Italy, from 1985 to 1989. 1991 1.07
35 Seroepidemiological study of an acute hepatitis E outbreak in Morocco. 1997 1.06
36 In vitro HIV1 infection of human cervical tissue. 1995 1.06
37 Changes in Rift Valley fever neutralizing antibody prevalence among small domestic ruminants following the 1987 outbreak in the Senegal River basin. 1991 1.06
38 Some properties of the viroid inducing peach latent mosaic disease. 1990 1.06
39 PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition? 1996 1.05
40 Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. 1990 1.04
41 Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection. 1997 1.04
42 A fifth human cytomegalovirus glycoprotein B genotype. 1998 1.03
43 PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent. 1993 1.02
44 Sequence characterization of the adenovirus 31 fibre and comparison with serotypes of subgenera A to F. 1996 1.02
45 Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251. 1998 1.02
46 On the HIV nef gene product. 1992 1.01
47 The hexon genes of adenoviruses of subgenus C: comparison of the variable regions. 1993 1.01
48 Analytical study of a Rift Valley fever epidemic. 1989 1.00
49 Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. 1995 1.00
50 The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. 1993 1.00
Next 50